Summary

Market Analysis and Insights: Global Hyperkalemia Treatment Market
The global Hyperkalemia Treatment market is valued at US$ 434.37 million in 2020. The market size will reach US$ 1682.53 million by the end of 2027, growing at a CAGR of 20.86% during 2021-2027.

Global Hyperkalemia Treatment Scope and Segment
Hyperkalemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hyperkalemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2016-2027.
By Company
Vifor Pharma
Astrazeneca
Sanofi
CMP Pharma
Belcher Pharmaceuticals

Segment by Type
Patiromer
Sodium Zirconium Cyclosilicate
Other

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other

Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia Europe
Germany
U.K.
France
Italy
Russia
Rest of Europe
South America
Brazil
Rest of South America
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Other Regions

ページTOPに戻る

Table of Contents

1 STUDY COVERAGE 1
1.1 Hyperkalemia Treatment Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Hyperkalemia Treatment Market Size Growth Rate by Type 2
1.2.2 Patiromer 3
1.2.3 Sodium Zirconium Cyclosilicate 4
1.2.4 Other 4
1.3 Market by Application 5
1.3.1 Global Hyperkalemia Treatment Market Size Growth Rate by Application 5
1.3.2 Hospital Pharmacy 7
1.3.3 Retail Pharmacy 7
1.4 Study Objectives 8
1.5 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Hyperkalemia Treatment Sales Estimates and Forecasts 2016-2027 10
2.2 Global Hyperkalemia Treatment Revenue Estimates and Forecasts 2016-2027 11
2.3 Global Hyperkalemia Treatment Revenue by Region: 2016 VS 2021 VS 2027 12
2.4 Global Top Hyperkalemia Treatment Regions by Sales 14
2.4.1 Global Top Hyperkalemia Treatment Regions by Sales (2016-2021) 14
2.4.2 Global Top Hyperkalemia Treatment Regions by Sales (2022-2027) 15
2.5 Global Top Hyperkalemia Treatment Regions by Revenue 16
2.5.1 Global Top Hyperkalemia Treatment Regions by Revenue (2016-2021) 16
2.5.2 Global Top Hyperkalemia Treatment Regions by Revenue (2022-2027) 17
2.6 North America 18
2.7 Europe 19
2.8 Asia-Pacific 20
2.9 South America 21
2.10 Middle East & Africa 22
3 COMPETITION BY MANUFACTURERS 23
3.1 Global Hyperkalemia Treatment Sales by Manufacturers 23
3.1.1 Global Top Hyperkalemia Treatment Manufacturers by Sales (2019-2021) 23
3.1.2 Global Top Hyperkalemia Treatment Manufacturers Market Share by Sales (2019-2021) 23
3.1.3 Global Top Companies by Hyperkalemia Treatment Sales in 2020 24
3.2 Global Hyperkalemia Treatment Revenue by Manufacturers 24
3.2.1 Global Top Hyperkalemia Treatment Manufacturers by Revenue (2019-2021) 24
3.2.2 Global Top Hyperkalemia Treatment Manufacturers Market Share by Revenue (2019-2021) 25
3.2.3 Global Top Companies by Hyperkalemia Treatment Revenue in 2020 26
3.3 Global Hyperkalemia Treatment Sales Price by Manufacturers 26
3.4 Analysis of Competitive Landscape 27
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 27
3.4.2 Global Hyperkalemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) 27
3.4.3 Global Hyperkalemia Treatment Manufacturers Geographical Distribution 28
3.5 Mergers & Acquisitions, Expansion Plans 29
4 MARKET SIZE BY TYPE 31
4.1 Global Hyperkalemia Treatment Sales by Type 31
4.1.1 Global Hyperkalemia Treatment Historical Sales by Type (2016-2021) 31
4.1.2 Global Hyperkalemia Treatment Forecasted Sales by Type (2022-2027) 31
4.1.3 Global Hyperkalemia Treatment Sales Market Share by Type (2016-2027) 31
4.2 Global Hyperkalemia Treatment Revenue by Type 32
4.2.1 Global Hyperkalemia Treatment Historical Revenue by Type (2016-2021) 32
4.2.2 Global Hyperkalemia Treatment Forecasted Revenue by Type (2022-2027) 33
4.2.3 Global Hyperkalemia Treatment Revenue Market Share by Type (2016-2027) 33
4.3 Global Hyperkalemia Treatment Price by Type 34
4.3.1 Global Hyperkalemia Treatment Price by Type (2016-2021) 34
4.3.2 Global Hyperkalemia Treatment Price Forecast by Type (2022-2027) 34
5 MARKET SIZE BY APPLICATION 35
5.1 Global Hyperkalemia Treatment Sales by Application 35
5.1.1 Global Hyperkalemia Treatment Historical Sales by Application (2016-2021) 35
5.1.2 Global Hyperkalemia Treatment Forecasted Sales by Application (2022-2027) 35
5.1.3 Global Hyperkalemia Treatment Sales Market Share by Application (2016-2027) 35
5.2 Global Hyperkalemia Treatment Revenue by Application 36
5.2.1 Global Hyperkalemia Treatment Historical Revenue by Application (2016-2021) 36
5.2.2 Global Hyperkalemia Treatment Forecasted Revenue by Application (2022-2027) 37
5.2.3 Global Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 37
5.3 Global Hyperkalemia Treatment Price by Application 38
5.3.1 Global Hyperkalemia Treatment Price by Application (2016-2021) 38
5.3.2 Global Hyperkalemia Treatment Price Forecast by Application (2022-2027) 38
6 NORTH AMERICA 39
6.1 North America Hyperkalemia Treatment Market Size by Type 39
6.1.1 North America Hyperkalemia Treatment Sales by Type (2016-2027) 39
6.1.2 North America Hyperkalemia Treatment Revenue by Type (2016-2027) 40
6.2 North America Hyperkalemia Treatment Market Size by Application 41
6.3 North America Hyperkalemia Treatment Market Size by Country 42
6.3.1 North America Hyperkalemia Treatment Sales by Country (2016-2027) 42
6.3.2 North America Hyperkalemia Treatment Revenue by Country (2016-2027) 43
6.3.3 United States 44
6.3.4 Canada 44
6.3.5 Mexico 45
7 EUROPE 46
7.1 Europe Hyperkalemia Treatment Market Size by Type 46
7.1.1 Europe Hyperkalemia Treatment Sales by Type (2016-2027) 46
7.1.2 Europe Hyperkalemia Treatment Revenue by Type (2016-2027) 47
7.2 Europe Hyperkalemia Treatment Market Size by Application 48
7.3 Europe Hyperkalemia Treatment Market Size by Country 49
7.3.1 Europe Hyperkalemia Treatment Sales by Country (2016-2027) 49
7.3.2 Europe Hyperkalemia Treatment Revenue by Country (2016-2027) 50
7.3.3 Germany 51
7.3.4 U.K. 52
7.3.5 France 52
7.3.6 Italy 53
7.3.7 Russia 53
8 ASIA PACIFIC 54
8.1 Asia Pacific Hyperkalemia Treatment Market Size by Type 54
8.1.1 Asia Pacific Hyperkalemia Treatment Sales by Type (2016-2027) 54
8.1.2 Asia Pacific Hyperkalemia Treatment Revenue by Type (2016-2027) 55
8.2 Asia Pacific Hyperkalemia Treatment Market Size by Application 56
8.3 Asia Pacific Hyperkalemia Treatment Market Size by Region 57
8.3.1 Asia Pacific Hyperkalemia Treatment Sales by Region (2016-2027) 57
8.3.2 Asia Pacific Hyperkalemia Treatment Revenue by Region (2016-2027) 58
8.3.3 China 59
8.3.4 Japan 60
8.3.5 South Korea 60
8.3.6 India 61
8.3.7 Southeast Asia 61
8.3.8 Australia 62
9 SOUTH AMERICA 63
9.1 South America Hyperkalemia Treatment Market Size by Type 63
9.1.1 South America Hyperkalemia Treatment Sales by Type (2016-2027) 63
9.1.2 South America Hyperkalemia Treatment Revenue by Type (2016-2027) 63
9.2 South America Hyperkalemia Treatment Market Size by Application 64
9.3 South America Hyperkalemia Treatment Market Size by Country 65
9.3.1 South America Hyperkalemia Treatment Sales by Country (2016-2027) 65
9.3.2 South America Hyperkalemia Treatment Revenue by Country (2016-2027) 65
9.3.3 Brazil 66
10 MIDDLE EAST AND AFRICA 67
10.1 Middle East and Africa Hyperkalemia Treatment Market Size by Type 67
10.1.1 Middle East and Africa Hyperkalemia Treatment Sales by Type (2016-2027) 67
10.1.2 Middle East and Africa Hyperkalemia Treatment Revenue by Type (2016-2027) 67
10.2 Middle East and Africa Hyperkalemia Treatment Market Size by Application 68
10.3 Middle East and Africa Hyperkalemia Treatment Market Size by Country 69
10.3.1 Middle East and Africa Hyperkalemia Treatment Sales by Country (2016-2027) 69
10.3.2 Middle East and Africa Hyperkalemia Treatment Revenue by Country (2016-2027) 70
10.3.3 Turkey 71
10.3.4 Saudi Arabia 72
10.3.5 U.A.E 72
11 CORPORATE PROFILE 73
11.1 Vifor Pharma 73
11.1.1 Vifor Pharma Corporation Information 73
11.1.2 Vifor Pharma Overview 73
11.1.3 Vifor Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021) 74
11.1.4 Vifor Pharma Hyperkalemia Treatment Product Description 74
11.1.5 Vifor Pharma Recent Developments 75
11.2 Astrazeneca 75
11.2.1 Astrazeneca Corporation Information 75
11.2.2 Astrazeneca Overview 75
11.2.3 Astrazeneca Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021) 76
11.2.4 Astrazeneca Hyperkalemia Treatment Product Description 76
11.2.5 Astrazeneca Recent Developments 77
11.3 Sanofi 78
11.3.1 Sanofi Corporation Information 78
11.3.2 Sanofi Overview 79
11.3.3 Sanofi Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021) 79
11.3.4 Sanofi Hyperkalemia Treatment Product Description 79
11.3.5 Sanofi Recent Developments 80
11.4 CMP Pharma 80
11.4.1 CMP Pharma Corporation Information 80
11.4.2 CMP Pharma Overview 81
11.4.3 CMP Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021) 81
11.4.4 CMP Pharma Hyperkalemia Treatment Product Description 82
11.5 Belcher Pharmaceuticals 83
11.5.1 Belcher Pharmaceuticals Corporation Information 83
11.5.2 Belcher Pharmaceuticals Overview 84
11.5.3 Belcher Pharmaceuticals Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021) 85
11.5.4 Belcher Pharmaceuticals Hyperkalemia Treatment Product Description 85
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 86
12.1 Hyperkalemia Treatment Value Chain Analysis 86
12.2 Hyperkalemia Treatment Key Raw Materials 87
12.2.1 Key Raw Materials 87
12.2.2 Raw Materials Key Suppliers 87
12.3 Hyperkalemia Treatment Sales and Marketing 88
12.3.1 Hyperkalemia Treatment Sales Channels 88
12.3.2 Hyperkalemia Treatment Distributors 90
12.4 Hyperkalemia Treatment Customers 92
13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 94
13.1 Hyperkalemia Treatment Industry Trends 94
13.2 Hyperkalemia Treatment Market Drivers 94
13.3 Hyperkalemia Treatment Market Challenges 95
13.4 Hyperkalemia Treatment Market Restraints 95
14 KEY FINDINGS IN THE GLOBAL HYPERKALEMIA TREATMENT STUDY 96
15 APPENDIX 98
15.1 Research Methodology 98
15.1.1 Methodology/Research Approach 98
15.1.2 Data Source 101
15.2 Author Details 104
15.3 Disclaimer 104






Table 1. Global Hyperkalemia Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) 2
Table 2. Major Manufacturers of Sodium Zirconium Cyclosilicate 4
Table 3. Global Hyperkalemia Treatment Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) 5
Table 4. Global Hyperkalemia Treatment Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) 12
Table 5. Global Hyperkalemia Treatment Sales by Region (2016-2021) & (K Unit) 14
Table 6. Global Hyperkalemia Treatment Sales Market Share by Region (2016-2021) 14
Table 7. Global Hyperkalemia Treatment Sales Market Share by Region (2016-2021) 15
Table 8. Global Hyperkalemia Treatment Sales by Region (2022-2027) & (K Unit) 15
Table 9. Global Hyperkalemia Treatment Sales Market Share by Region (2022-2027) 15
Table 10. Global Hyperkalemia Treatment Sales Market Share by Region (2022-2027) 16
Table 11. Global Hyperkalemia Treatment Revenue by Region (2016-2021) & (US$ Million) 16
Table 12. Global Hyperkalemia Treatment Revenue Market Share by Region (2016-2021) 16
Table 13. Global Hyperkalemia Treatment Revenue by Region (2022-2027) & (US$ Million) 17
Table 14. Global Hyperkalemia Treatment Revenue Market Share by Region (2022-2027) 17
Table 15. Global Hyperkalemia Treatment Sales by Manufacturers (2019-2021) & (K Unit) 23
Table 16. Global Hyperkalemia Treatment Sales Share by Manufacturers (2019-2021) 23
Table 17. Global Hyperkalemia Treatment Revenue by Manufacturers (2019-2021) & (US$ Million) 25
Table 18. Global Hyperkalemia Treatment Revenue Share by Manufacturers (2019-2021) 25
Table 19. Hyperkalemia Treatment Price by Manufacturers 2019-2021 (USD/Unit) 26
Table 20. Global Hyperkalemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) 27
Table 21. Global Hyperkalemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperkalemia Treatment as of 2020) 28
Table 22. Hyperkalemia Treatment Manufacturing Base Distribution and Headquarters 28
Table 23. Manufacturers Hyperkalemia Treatment Product Offered 28
Table 24. Date of Manufacturers Enter into Hyperkalemia Treatment Market 29
Table 25. Mergers & Acquisitions, Expansion Plans 29
Table 26. Global Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit) 31
Table 27. Global Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit) 31
Table 28. Global Hyperkalemia Treatment Sales Share by Type (2016-2021) 31
Table 29. Global Hyperkalemia Treatment Sales Share by Type (2022-2027) 32
Table 30. Global Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million) 32
Table 31. Global Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million) 33
Table 32. Global Hyperkalemia Treatment Revenue Share by Type (2016-2021) 33
Table 33. Global Hyperkalemia Treatment Revenue Share by Type (2022-2027) 33
Table 34. Hyperkalemia Treatment Price by Type (2016-2021) & (USD/Unit) 34
Table 35. Global Hyperkalemia Treatment Price Forecast by Type (2022-2027) & (USD/Unit) 34
Table 36. Global Hyperkalemia Treatment Sales by Application (2016-2021) & (K Unit) 35
Table 37. Global Hyperkalemia Treatment Sales by Application (2022-2027) & (K Unit) 35
Table 38. Global Hyperkalemia Treatment Sales Share by Application (2016-2021) 35
Table 39. Global Hyperkalemia Treatment Sales Share by Application (2022-2027) 36
Table 40. Global Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million) 36
Table 41. Global Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million) 37
Table 42. Global Hyperkalemia Treatment Revenue Share by Application (2016-2021) 37
Table 43. Global Hyperkalemia Treatment Revenue Share by Application (2022-2027) 37
Table 44. Hyperkalemia Treatment Price by Application (2016-2021) & (USD/Unit) 38
Table 45. Global Hyperkalemia Treatment Price Forecast by Application (2022-2027) & (USD/Unit) 38
Table 46. North America Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit) 39
Table 47. North America Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit) 39
Table 48. North America Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million) 40
Table 49. North America Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million) 40
Table 50. North America Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million) 41
Table 51. North America Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million) 41
Table 52. North America Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit) 42
Table 53. North America Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit) 42
Table 54. North America Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million) 43
Table 55. North America Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million) 43
Table 56. Europe Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit) 46
Table 57. Europe Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit) 46
Table 58. Europe Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million) 47
Table 59. Europe Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million) 47
Table 60. Europe Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million) 48
Table 61. Europe Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million) 48
Table 62. Europe Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit) 49
Table 63. Europe Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit) 49
Table 64. Europe Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million) 50
Table 65. Europe Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million) 50
Table 66. Asia Pacific Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit) 54
Table 67. Asia Pacific Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit) 54
Table 68. Asia Pacific Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million) 55
Table 69. Asia Pacific Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million) 55
Table 70. Asia Pacific Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million) 56
Table 71. Asia Pacific Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million) 56
Table 72. Asia Pacific Hyperkalemia Treatment Sales by Region (2016-2021) & (K Unit) 57
Table 73. Asia Pacific Hyperkalemia Treatment Sales by Region (2022-2027) & (K Unit) 57
Table 74. Asia Pacific Hyperkalemia Treatment Revenue by Region (2016-2021) & (US$ Million) 58
Table 75. Asia Pacific Hyperkalemia Treatment Revenue by Region (2022-2027) & (US$ Million) 58
Table 76. South America Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit) 63
Table 77. South America Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit) 63
Table 78. South America Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million) 63
Table 79. South America Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million) 63
Table 80. South America Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million) 64
Table 81. South America Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million) 64
Table 82. South America Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit) 65
Table 83. South America Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit) 65
Table 84. South America Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million) 65
Table 85. South America Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million) 65
Table 86. Middle East and Africa Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit) 67
Table 87. Middle East and Africa Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit) 67
Table 88. Middle East and Africa Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million) 67
Table 89. Middle East and Africa Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million) 68
Table 90. Middle East and Africa Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million) 68
Table 91. Middle East and Africa Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million) 68
Table 92. Middle East and Africa Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit) 69
Table 93. Middle East and Africa Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit) 70
Table 94. Middle East and Africa Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million) 70
Table 95. Middle East and Africa Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million) 71
Table 96. Vifor Pharma Corporation Information 73
Table 97. Vifor Pharma Description and Major Businesses 73
Table 98. Vifor Pharma Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021) 74
Table 99. Vifor Pharma Hyperkalemia Treatment Product 74
Table 100. Vifor Pharma Recent Developments 75
Table 101. Astrazeneca Corporation Information 75
Table 102. Astrazeneca Description and Major Businesses 75
Table 103. Astrazeneca Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021) 76
Table 104. Astrazeneca Hyperkalemia Treatment Product 76
Table 105. Astrazeneca Recent Developments 77
Table 106. Sanofi Corporation Information 78
Table 107. Sanofi Description and Major Businesses 79
Table 108. Sanofi Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021) 79
Table 109. Sanofi Hyperkalemia Treatment Product 79
Table 110. Sanofi Recent Developments 80
Table 111. CMP Pharma Corporation Information 80
Table 112. CMP Pharma Description and Major Businesses 81
Table 113. CMP Pharma Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021) 81
Table 114. CMP Pharma Hyperkalemia Treatment Product 82
Table 115. Belcher Pharmaceuticals Corporation Information 83
Table 116. Belcher Pharmaceuticals Description and Major Businesses 84
Table 117. Belcher Pharmaceuticals Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021) 85
Table 118. Belcher Pharmaceuticals Hyperkalemia Treatment Product 85
Table 119. Key Raw Materials Lists 87
Table 120. Raw Materials Key Suppliers Lists 87
Table 121. Hyperkalemia Treatment Distributors List 90
Table 122. Hyperkalemia Treatment Customers List 92
Table 123. Hyperkalemia Treatment Market Trends 94
Table 124. Hyperkalemia Treatment Market Drivers 94
Table 125. Hyperkalemia Treatment Market Challenges 95
Table 126. Hyperkalemia Treatment Market Restraints 95
Table 127. Research Programs/Design for This Report 98
Table 128. Key Data Information from Secondary Sources 101
Table 129. Key Data Information from Primary Sources 102



List of Figures

Figure 1. Hyperkalemia Treatment Product Picture 1
Figure 2. Global Hyperkalemia Treatment Market Share by Type in 2020 2
Figure 3. Global Hyperkalemia Treatment Market Share by Type in 2027 3
Figure 4. Patiromer Product Picture 3
Figure 5. Major Manufacturers of Patiromer 4
Figure 6. Sodium Zirconium Cyclosilicate Product Picture 4
Figure 7. Other Product Picture 5
Figure 8. Global Hyperkalemia Treatment Market Share by Application in 2020 6
Figure 9. Global Hyperkalemia Treatment Market Share by Application in 2027 6
Figure 10. Hospital Pharmacy 7
Figure 11. Retail Pharmacy 8
Figure 12. Hyperkalemia Treatment Report Years Considered 9
Figure 13. Global Hyperkalemia Treatment Sales 2016-2027 (K Unit) 10
Figure 14. Global Hyperkalemia Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 11
Figure 15. Global Hyperkalemia Treatment Revenue 2016-2027 (US$ Million) 12
Figure 16. Global Hyperkalemia Treatment Revenue Market Share by Region in Percentage: 2020 13
Figure 17. Global Hyperkalemia Treatment Revenue Market Share by Region in Percentage: 2027 13
Figure 18. North America Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit) 18
Figure 19. North America Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million) 18
Figure 20. Europe Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit) 19
Figure 21. Europe Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million) 19
Figure 22. Asia-Pacific Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit) 20
Figure 23. Asia-Pacific Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million) 20
Figure 24. South America Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit) 21
Figure 25. South America Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million) 21
Figure 26. Middle East & Africa Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit) 22
Figure 27. Middle East & Africa Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million) 22
Figure 28. The Top Players Market Share by Hyperkalemia Treatment Sales in 2020 24
Figure 29. The Top Players Market Share by Hyperkalemia Treatment Revenue in 2020 26
Figure 30. Global Hyperkalemia Treatment Sales Market Share by Type (2016-2027) 32
Figure 31. Global Hyperkalemia Treatment Revenue Market Share by Type (2016-2027) 34
Figure 32. Global Hyperkalemia Treatment Sales Market Share by Application (2016-2027) 36
Figure 33. Global Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 38
Figure 34. North America Hyperkalemia Treatment Sales Market Share by Type (2016-2027) 39
Figure 35. North America Hyperkalemia Treatment Revenue Market Share by Type (2016-2027) 40
Figure 36. North America Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 41
Figure 37. North America Hyperkalemia Treatment Sales Share by Country (2016-2027) 42
Figure 38. North America Hyperkalemia Treatment Revenue Share by Country (2016-2027) 43
Figure 39. United States Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 44
Figure 40. Canada Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 44
Figure 41. Mexico Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 45
Figure 42. Europe Hyperkalemia Treatment Sales Market Share by Type (2016-2027) 46
Figure 43. Europe Hyperkalemia Treatment Revenue Market Share by Type (2016-2027) 47
Figure 44. Europe Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 48
Figure 45. Europe Hyperkalemia Treatment Sales Share by Country (2016-2027) 50
Figure 46. Europe Hyperkalemia Treatment Revenue Share by Country (2016-2027) 51
Figure 47. Germany Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 51
Figure 48. U.K. Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 52
Figure 49. France Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 52
Figure 50. Italy Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 53
Figure 51. Russia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 53
Figure 52. Asia Pacific Hyperkalemia Treatment Sales Market Share by Type (2016-2027) 54
Figure 53. Asia Pacific Hyperkalemia Treatment Revenue Market Share by Type (2016-2027) 55
Figure 54. Asia Pacific Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 56
Figure 55. Asia Pacific Hyperkalemia Treatment Sales Share by Region (2016-2027) 58
Figure 56. Asia Pacific Hyperkalemia Treatment Revenue Share by Region (2016-2027) 59
Figure 57. China Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 59
Figure 58. Japan Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 60
Figure 59. South Korea Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 60
Figure 60. India Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 61
Figure 61. Southeast Asia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 61
Figure 62. Australia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 62
Figure 63. South America Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 64
Figure 64. Brazil Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 66
Figure 65. Middle East and Africa Hyperkalemia Treatment Revenue Market Share by Application (2016-2027) 69
Figure 66. Middle East and Africa Hyperkalemia Treatment Sales Share by Country (2016-2027) 70
Figure 67. Turkey Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 71
Figure 68. Saudi Arabia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 72
Figure 69. U.A.E Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million) 72
Figure 70. Hyperkalemia Treatment Value Chain 86
Figure 71. Channels of Distribution 89
Figure 72. Distributors Profiles 91
Figure 73. Bottom-up and Top-down Approaches for This Report 100
Figure 74. Data Triangulation 101
Figure 75. Key Executives Interviewed 103